Substituted pyrrolo[2.3-B]pyridines

Compounds represented by Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, are inhibitors of least two of the Abl, Aurora-A, Blk, c-Raf, cSRC, Src, PRK2, FGFR3, Flt3, Lck, Mek1, PDK-1, GSK3beta, EGFR, p70S6K, BMX, SGK, CaMKII, Tie-2, IGF-1R, Ron, Ret, and KDR kinases in ani...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AHMED SALEH, DAWSON GRAHAM, WENG QINGHUA ('FELIX'), PEGG NEIL ANTHONY, TAVARES PAULA, SAMBROOK SMITH COLIN PETER, SMYTH DON, SADIQ SHAZIA, STOLZ KATHRYN, BLOXHAM JASON, LI AN-HU, DONG HANQING, BARBA OSCAR, PANICKER BIJOY, STEINIG AMO G, FOREMAN KENNETH ('KEN'), WILKES ROBIN, COX MATTHEW, KITCHIN JOHN, SABA IMAAD, MA LIFU, GATTRELL WILLIAM
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds represented by Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, are inhibitors of least two of the Abl, Aurora-A, Blk, c-Raf, cSRC, Src, PRK2, FGFR3, Flt3, Lck, Mek1, PDK-1, GSK3beta, EGFR, p70S6K, BMX, SGK, CaMKII, Tie-2, IGF-1R, Ron, Ret, and KDR kinases in animals, including humans, for the treatment and/or prevention of various diseases and conditions such as cancer.